SCHEMBL4469120

SCHEMBL4469120

O=C(C1=COC(c2ccccc2Cl)O1)C1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
HTR6 P50406 5/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
RIPK1 Q13546 1/20 0.34
STAT3 P40763 1/20 0.33
STAT1 P42224 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
ROCK2 O75116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4460926 0.71 PKM (0.44) KMT2A
SCHEMBL3709504 0.70 HTR3E (0.56) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL3714989 0.68 HTR3E (0.55) HTR3EHTR3BHTR3AHTR3DHTR3C
Bromide SCHEMBL11199812 0.68 HTR3E (0.55) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5370319 0.68 ALDH1A1 (0.35) KMT2AMEN1CYP2D6
SCHEMBL3962252 0.65 HTR2C (0.60) HTR6HTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL4986865 0.65 SMN1; SMN2 (0.36) KMT2AMEN1HRH3
SCHEMBL2473331 0.64 KMT2A (0.35) KMT2AMEN1
Hydrochloric Acid SCHEMBL30952434 0.64 HTR2C (0.61) HTR6HTR1ASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL1765134 0.64 HTR2C (0.61) HTR6HTR1ASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 HTR3E 356/4885HTR3B 325/4885HTR3A 476/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 HTR3E 595/4885HTR3B 531/4885HTR3A 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.